tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
BeOne Medicines Grants New RSUs to 188 Employees Under Incentive Plan
PremiumCompany AnnouncementsBeOne Medicines Grants New RSUs to 188 Employees Under Incentive Plan
14d ago
KURE vs. VHT: Comparing China and U.S. Healthcare ETFs
Premium
Market News
KURE vs. VHT: Comparing China and U.S. Healthcare ETFs
18d ago
Zymeworks, Royalty Pharma enter $250M royalty-backed note financing
Premium
The Fly
Zymeworks, Royalty Pharma enter $250M royalty-backed note financing
18d ago
BeOne Medicines price target raised to $405 from $394 at Barclays
PremiumThe FlyBeOne Medicines price target raised to $405 from $394 at Barclays
21d ago
BeOne Medicines Files 2025 Form 10-K, Underscoring Cross-Border Compliance
Premium
Company Announcements
BeOne Medicines Files 2025 Form 10-K, Underscoring Cross-Border Compliance
22d ago
BeOne Medicines posts 2025 results and issues cautious 2026 outlook
Premium
Company Announcements
BeOne Medicines posts 2025 results and issues cautious 2026 outlook
22d ago
BeOne Medicines Grants New RSUs to 246 Employees Under Incentive Plan
PremiumCompany AnnouncementsBeOne Medicines Grants New RSUs to 246 Employees Under Incentive Plan
2M ago
BeOne Medicines upgraded to Outperform from Market Perform at Bernstein
Premium
The Fly
BeOne Medicines upgraded to Outperform from Market Perform at Bernstein
2M ago
BeOne Medicines price target raised to $405 from $390 at Morgan Stanley
Premium
The Fly
BeOne Medicines price target raised to $405 from $390 at Morgan Stanley
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100